CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,678,894
- in 11 filings, $1.7M under 10b5-1 plans
Net −$1,678,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-31 | Shannon John Patrick Jr See Remarks | Shares withheld for taxes | −110,750 | $3.56 | $394K | 1,997,868 |
| 2025-01-31 | Shannon John Patrick Jr See Remarks | Shares withheld for taxes | −110,750 | $3.56 | $394K | 1,887,118 |
| 2025-01-31 | Shannon John Patrick Jr See Remarks | Grant or award | +800,000 | 2,687,118 | ||
| 2025-01-31 | Shannon John Patrick Jr See Remarks | Grant or award · Stock Appreciation Right | +600,000 | 600,000 | ||
| 2025-01-31 | Hecht Beth See Remarks | Shares withheld for taxes | −45,909 | $3.56 | $163K | 1,306,885 |
| 2025-01-31 | Hecht Beth See Remarks | Shares withheld for taxes | −98,375 | $3.56 | $350K | 1,208,510 |
| 2025-01-31 | Hecht Beth See Remarks | Grant or award | +185,000 | 1,393,510 | ||
| 2025-01-31 | Hecht Beth See Remarks | Grant or award · Stock Appreciation Right | +300,000 | 300,000 | ||
| 2025-01-31 | Pieper Steven See Remarks | Shares withheld for taxes | −110,750 | $3.56 | $394K | 1,299,011 |
| 2025-01-31 | Pieper Steven See Remarks | Shares withheld for taxes | −66,450 | $3.56 | $237K | 1,232,561 |
| 2025-01-31 | Pieper Steven See Remarks | Grant or award | +185,000 | 1,417,561 | ||
| 2025-01-31 | Pieper Steven See Remarks | Grant or award · Stock Appreciation Right | +300,000 | 300,000 | ||
| 2025-01-31 | JOHNSON KENNETH ERLAND See Remarks | Shares withheld for taxes | −15,476 | $3.56 | $55K | 346,288 |
| 2025-01-31 | JOHNSON KENNETH ERLAND See Remarks | Shares withheld for taxes | −25,842 | $3.56 | $92K | 320,446 |
| 2025-01-03 | Shannon John Patrick Jr See Remarks | Shares withheld for taxes | −39,443 | $3.61 | $142K | 2,108,618 |
| 2025-01-03 | McCulloch Kevin See Remarks | Shares withheld for taxes | −24,501 | $3.61 | $88K | 1,577,452 |
| 2025-01-03 | JOHNSON KENNETH ERLAND See Remarks | Shares withheld for taxes | −12,401 | $3.61 | $45K | 361,764 |
| 2025-01-03 | Pieper Steven See Remarks | Shares withheld for taxes | −32,059 | $3.61 | $116K | 1,409,761 |
| 2025-01-03 | Hecht Beth See Remarks | Shares withheld for taxes | −32,039 | $3.61 | $116K | 1,352,794 |
| 2024-11-22 | Pieper Steven See Remarks | Option exercise | +19,483 | $1.55 | $30K | 1,441,820 |
Page 7 of 10 · 200 trades